|
1
|
Kato Y, Fujita N, Kunita A, Sato S, Kaneko
M, Osawa M and Tsuruo T: Molecular identification of Aggrus/T1alpha
as a platelet aggregation-inducing factor expressed in colorectal
tumors. J Biol Chem. 278:51599–51605. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaneko M, Kato Y, Kunita A, Fujita N,
Tsuruo T and Osawa M: Functional sialylated O-glycan to platelet
aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in
Chinese hamster ovary cells. J Biol Chem. 279:38838–38843. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Breiteneder-Geleff S, Soleiman A, Kowalski
H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler
E, Alitalo K, et al: Angiosarcomas express mixed endothelial
phenotypes of blood and lymphatic capillaries: Podoplanin as a
specific marker for lymphatic endothelium. Am J Pathol.
154:385–394. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsui K, Breitender-Geleff S, Soleiman A,
Kowalski H and Kerjaschki D: Podoplanin, a novel 43-kDa membrane
protein, controls the shape of podocytes. Nephrol Dial Transplant.
14(Suppl 1): 9–11. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rishi AK, Joyce-Brady M, Fisher J, Dobbs
LG, Floros J, VanderSpek J, Brody JS and Williams MC: Cloning,
characterization, and development expression of a rat lung alveolar
type I cell gene in embryonic endodermal and neural derivatives.
Dev Biol. 167:294–306. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schacht V, Dadras SS, Johnson LA, Jackson
DG, Hong YK and Detmar M: Up-regulation of the lymphatic marker
podoplanin, a mucin-type transmembrane glycoprotein, in human
squamous cell carcinomas and germ cell tumors. Am J Pathol.
166:913–921. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ordóñez NG: The diagnostic utility of
immunohistochemistry and electron microscopy in distinguishing
between peritoneal mesotheliomas and serous carcinomas: A
comparative study. Mod Pathol. 19:34–48. 2006. View Article : Google Scholar
|
|
8
|
Wicki A and Christofori G: The potential
role of podoplanin in tumour invasion. Br J Cancer. 96:1–5. 2007.
View Article : Google Scholar
|
|
9
|
Kato Y, Kaneko M, Sata M, Fujita N, Tsuruo
T and Osawa M: Enhanced expression of Aggrus (T1alpha/podoplanin),
a platelet-aggregation-inducing factor in lung squamous cell
carcinoma. Tumour Biol. 26:195–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kato Y, Sasagawa I, Kaneko M, Osawa M,
Fujita N and Tsuruo T: Aggrus: A diagnostic marker that
distinguishes seminoma from embryonal carcinoma in testicular germ
cell tumors. Oncogene. 23:8552–8556. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kimura N and Kimura I: Podoplanin as a
marker for mesothelioma. Pathol Int. 55:83–86. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martin-Villar E, Scholl FG, Gamallo C,
Yurrita MM, Muñoz-Guerra M, Cruces J and Quintanilla M:
Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a
small membrane mucin induced in oral squamous cell carcinomas. Int
J Cancer. 113:899–910. 2005. View Article : Google Scholar
|
|
13
|
Mishima K, Kato Y, Kaneko MK, Nishikawa R,
Hirose T and Matsutani M: Increased expression of podoplanin in
malignant astrocytic tumors as a novel molecular marker of
malignant progression. Acta Neuropathol. 111:483–488. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Naqvi J, Ordonez NG, Luna MA, Williams MD,
Weber RS and El-Naggar AK: Epithelioid hemangioendothelioma of the
head and neck: Role of podoplanin in the differential diagnosis.
Head Neck Pathol. 2:25–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wicki A, Lehembre F, Wick N, Hantusch B,
Kerjaschki D and Christofori G: Tumor invasion in the absence of
epithelial-mesenchymal transition: Podoplanin-mediated remodeling
of the actin cytoskeleton. Cancer Cell. 9:261–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Y, Sato F, Yamada T, et al: The BHLH
transcription factor DEC1 plays an important role in the
epithelial-mesenchymal transition of pancreatic cancer. Int J
Oncol. 41:1337–1346. 2012.PubMed/NCBI
|
|
20
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rahadiani N, Ikeda J, Makino T, Tian T,
Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K and Morii E: Tumorigenic
role of podoplanin in esophageal squamous-cell carcinoma. Ann Surg
Oncol. 17:1311–1323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Honma S, Kawamoto T, Takagi Y, Fujimoto K,
Sato F, Noshiro M, Kato Y and Honma K: Dec1 and Dec2 are regulators
of the mammalian molecular clock. Nature. 419:841–844. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kawase A, Ishii G, Nagai K, Ito T, Nagano
T, Murata Y, Hishida T, Nishimura M, Yoshida J, Suzuki K, et al:
Podoplanin expression by cancer associated fibroblasts predicts
poor prognosis of lung adenocarcinoma. Int J Cancer. 123:1053–1059.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamanashi T, Nakanishi Y, Fujii G,
Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M and Hirohashi S:
Podoplanin expression identified in stromal fibroblasts as a
favorable prognostic marker in patients with colorectal carcinoma.
Oncology. 77:53–62. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carvalho FM, Zaganelli FL, Almeida BG,
Goes JC, Baracat EC and Carvalho JP: Prognostic value of podoplanin
expression in intratumoral stroma and neoplastic cells of uterine
cervical carcinomas. Clinics (Sao Paulo). 65:1279–1283. 2010.
View Article : Google Scholar
|
|
26
|
Gandarillas A, Scholl FG, Benito N,
Gamallo C and Quintanilla M: Induction of PA2.26, a cell-surface
antigen expressed by active fibroblasts, in mouse epidermal
keratinocytes during carcinogenesis. Mol Carcinog. 20:10–18. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Honma M, Minami-Hori M, Takahashi H and
Iizuka H: Podoplanin expression in wound and hyperproliferative
psoriatic epidermis: Regulation by TGF-beta and STAT-3 activating
cytokines, IFN-gamma, IL-6, and IL-22. J Dermatol Sci. 65:134–140.
2012. View Article : Google Scholar
|
|
28
|
Nose K, Saito H and Kuroki T: Isolation of
a gene sequence induced later by tumor-promoting
12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells
(MC3T3-E1) and expressed constitutively in ras-transformed cells.
Cell Growth Differ. 1:511–518. 1990.PubMed/NCBI
|
|
29
|
Scholl FG, Gamallo C, Vilaro S and
Quintanilla M: Identification of PA2.26 antigen as a novel
cell-surface mucin-type glycoprotein that induces plasma membrane
extensions and increased motility in keratinocytes. J Cell Sci.
112:4601–4613. 1999.PubMed/NCBI
|
|
30
|
Suzuki H, Kato Y, Kaneko MK, Okita Y,
Narimatsu H and Kato M: Induction of podoplanin by transforming
growth factor-beta in human fibrosarcoma. FEBS Lett. 582:341–345.
2008. View Article : Google Scholar
|
|
31
|
Perl AK, Wilgenbus P, Dahl U, Semb H and
Christofori G: A causal role for E-cadherin in the transition from
adenoma to carcinoma. Nature. 392:190–193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li G and Herlyn M: Dynamics of
intercellular communication during melanoma development. Mol Med
Today. 6:163–169. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martin-Villar E, Megias D, Castel S,
Yurrita MM, Vilaro S and Quintanilla M: Podoplanin binds ERM
proteins to activate RhoA and promote epithelial-mesenchymal
transition. J Cell Sci. 119:4541–4553. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sato F, Bhawal UK, Kawamoto T, Fujimoto K,
Imaizumi T, Imanaka T, Kondo J, Koyanagi S, Noshiro M, Yoshida H,
et al: Basic-helix-loop-helix (bHLH) transcription factor DEC2
negatively regulates vascular endothelial growth factor expression.
Genes Cells. 13:131–144. 2008. View Article : Google Scholar : PubMed/NCBI
|
